Paula K. Cobb


Paula K. Cobb was named Chief Operating Officer of Decibel Therapeutics in 2019; she previously was Decibel’s Executive Vice President, Corporate Development from 2016 to 2018. From 2003 to 2016, Ms. Cobb held numerous positions with Biogen, including Senior Vice President, Rare Disease Group, Senior Vice President, MS Franchise Strategy and Vice President, Program Leadership & Management.  She also served on the Board of Directors of Nightstar Therapeutics plc from 2018 until it was acquired by Biogen in 2019.  Ms. Cobb earned her B.A. from Amherst College and her M.B.A. from Harvard University’s Graduate School of Business Administration.